Screener
Charles River Laboratories CRL Noncontrolling Interest, Increase (Decrease) in Redemption Value
Noncontrolling Interest, Increase (Decrease) in Redemption Value at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept crl:NoncontrollingInterestIncreaseDecreaseInRedemptionValue.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | Redeemable Noncontrolling Interests | Common Stock / Shares | Common Stock / Amount | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Treasury Stock / Shares | Treasury Stock / Amount | Total Charles River Laboratories, Inc. Equity | Noncontrolling Interest | Total Equity |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | 187 | — | — | — | (1,482) | — | — | — | (1,482) | 535 | (947) |
| Other comprehensive loss, net of tax | (554) | — | — | — | — | (4,947) | — | — | (4,947) | — | (4,947) |
| Dividends declared to noncontrolling interests | (606) | — | — | — | — | — | — | — | — | — | — |
| Adjustment of redeemable noncontrolling interest to redemption value | 1,610 | — | — | (1,610) | — | — | — | — | (1,610) | — | (1,610) |
| Issuance of stock under employee compensation plans | — | 208 | 3 | 496 | — | — | — | — | 499 | — | 499 |
| Purchase of treasury shares | — | — | — | — | — | — | 647 | (112,437) | (112,437) | — | (112,437) |
| Share repurchase excise tax | — | — | — | — | — | — | — | (762) | (762) | — | (762) |
| Stock-based compensation | — | — | — | 19,781 | — | — | — | — | 19,781 | — | 19,781 |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's noncontrolling interest, increase (decrease) in redemption value?
- Charles River Laboratories (CRL) reported noncontrolling interest, increase (decrease) in redemption value of $1.61M in Q2 2026.
- How has Charles River Laboratories's noncontrolling interest, increase (decrease) in redemption value changed year-over-year?
- Charles River Laboratories's noncontrolling interest, increase (decrease) in redemption value decreased by 32.4% year-over-year, from $2.38M to $1.61M.
- What does noncontrolling interest, increase (decrease) in redemption value mean?
- Noncontrolling Interest, Increase (Decrease) in Redemption Value as reported by Charles River Laboratories International, Inc..
Ask your AI about Charles River Laboratories's noncontrolling interest, increase (decrease) in redemption value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude